Fiona Law, Partner at Potter Clarkson, and David Lancaster, Partner at Pinsent Masons, sat down with CIC’s Michael Anstey to discuss the importance of an IP strategy and how to effectively monetise an established portfolio of patents.
Fiona Law
Fiona is a Partner at Potter Clarkson. She is an experienced patent attorney predominantly working with UK SMEs, investors and entrepreneurs in the Life Sciences sector. She has extensive experience helping companies create and shape their IP strategies and worldwide patent portfolios. Her work with investors makes her ideally positioned to test the strength of a business’ IP strategy and assess whether the IP is adding value to the company. Fiona has guided her clients through multiple fund-raising rounds and partnering processes, helping them raise well in excess of £200 million in the past couple of years alone. She was recognised as one of Management Today’s ’35 under 35′ for accomplishments in intellectual property. Fiona is a pharmacologist and chemist by background but has worked with all kinds of technologies in the Life Sciences sector, including everything from cell therapeutics to digital health.
David Lancaster
David is a Partner in the IP team at Pinsent Masons LLP in London. David has an undergraduate degree in biochemistry and a PhD in biological chemistry. He regularly advises innovator, generic and biologic companies on a wide range of contentious patent matters. David is a qualified barrister and represents clients in proceedings before the UK courts, particularly in cases relating to innovative biologic medicines and biosimilars. He is often involved in the co-ordination of multi-jurisdictional patent actions before national courts in Europe and at the European Patent Office. David regularly provides strategic advice relating to pharmaceutical product launches together with freedom to operate and due diligence advice to clients in the Life Sciences sector.
